Eric Donnelly
| Eric Donnelly | |
| Occupation | Radiation oncologist, academic |
|---|---|
Eric Donnelly is a radiation oncologist affiliated with the University of New Hampshire in Durham. His research addresses the treatment of endometrial cancer and breast cancer, including risk classification approaches and comparisons of radiotherapy strategies.[1]
Research
According to Semantic Scholar, Donnelly has authored or co-authored 114 papers that have collectively been cited 1,702 times, yielding an h-index of 21.[2] His work has examined the prevalence of POLE and POLD1 mutations and their relationship to race and survival among patients with endometrial cancer, published in JAMA Network Open.[3] He has also contributed to the development of a machine learning-based risk classification score for endometrial cancer patients, published in both the International Journal of Radiation Oncology, Biology, Physics and Gynecologic Oncology.[4][5]
In breast cancer research, Donnelly has studied treatment strategies for oligometastatic disease and compared outcomes among patients receiving external beam radiotherapy, intraoperative radiotherapy, or observation.[6][7] He has additionally presented findings on the avoidance of radiotherapy for low-risk early breast cancer using LUMINA trial criteria and on comparisons between radiotherapy and endocrine therapy for hormone receptor positive early stage breast cancer.[8][9]
Selected publications
- Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer (2024)
- 2036: Race, Prevalence of POLE and POLD1, Mutations, and Survival Among Patients With Endometrial Cancer (2024)
- A Cost-Effective, Machine Learning-Based New Unified Risk-Classification Score (NU-CATS) for Patients with Endometrial Cancer (2023)
- Treatment of Endometrial Cancer (2023)
- Assessment of Pain Management in Patients Referred to Radiation Oncology for Palliation of Acute Pain Symptoms (2022)
- Abstract PD7-04: Avoidance of radiotherapy for low risk early breast cancer using LUMINA Trial criteria and accounting for endocrine therapy adherence (2022)
- Abstract P1-13-03: Radiotherapy vs. endocrine therapy for hormone receptor positive early stage breast cancer accounting for endocrine therapy adherence (2022)
- Treatment Strategies for Oligometastatic Breast Cancer (2021)
- A Comparison of Outcomes in Early Breast Cancer After External Beam Radiotherapy, Intraoperative Radiotherapy, or Observation: A Retrospective Cohort Study Across a Large Health System (2021)
External links
- ↑ Semantic Scholar author profile for Eric Donnelly
- ↑ Semantic Scholar author profile for Eric Donnelly
- ↑ Eric Donnelly et al., "Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer," JAMA Network Open, 2024
- ↑ Eric Donnelly et al., "A Cost-Effective, Machine Learning-Based New Unified Risk-Classification Score (NU-CATS) for Patients with Endometrial Cancer," International Journal of Radiation Oncology, Biology, Physics, 2023
- ↑ Eric Donnelly et al., "A cost-effective, machine learning-based new unified risk-classification score (NU-CATS) for patients with endometrial cancer," Gynecologic Oncology, 2023
- ↑ Eric Donnelly et al., "Treatment Strategies for Oligometastatic Breast Cancer," Current Treatment Options in Oncology, 2021
- ↑ Eric Donnelly et al., "A Comparison of Outcomes in Early Breast Cancer After External Beam Radiotherapy, Intraoperative Radiotherapy, or Observation: A Retrospective Cohort Study Across a Large Health System," International Journal of Radiation Oncology, Biology, Physics, 2021
- ↑ Eric Donnelly et al., "Abstract PD7-04: Avoidance of radiotherapy for low risk early breast cancer using LUMINA Trial criteria and accounting for endocrine therapy adherence," Cancer Research, 2022
- ↑ Eric Donnelly et al., "Abstract P1-13-03: Radiotherapy vs. endocrine therapy for hormone receptor positive early stage breast cancer accounting for endocrine therapy adherence," Cancer Research, 2022